GSE193699
OX40 agonism enhances efficacy of PD-L1 checkpoint blockade by shifting the cytotoxic T cell differentiation spectrum
Immunotherapy effect on T cells in C57BL/6 mice Overall design: Single cell RNA-sequencing of 4 different blood samples withdrawn from 4 different treated mice treadted by : UNT (Untreated), PDL1 (PD-L1 treated), OX40 (OX40 treated) and PDOX (PDOX treated)